Navigation Links
Reportlinker Adds Pharma 101: An Overview of the Life Sciences Industry (Analyst Insight)
Date:10/16/2009

NEW YORK, Oct. 16 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue.

Reportlinker Adds Pharma 101: An Overview of the Life Sciences Industry (Analyst Insight)

http://www.reportlinker.com/p0155107/Reportlinker-Adds-Pharma-101-An-Overview-of-the-Life-Sciences-Industry-(Analyst-Insight).html

Introduction

The life sciences industry is unique and complex. Without having the proper background, it can be difficult for IT vendors to enter this conservative market. Those willing to put in the extra effort to truly understand the pharmaceutical and biotechnology industries will realize there is considerable opportunity for technology.

Scope

*Offers an overview of the pharmaceutical and biotechnology industries

*Discusses key areas where technology would be most beneficial in the life sciences industry

*Provides go-to-market strategies to help penetrate the pharma and biotech markets

Highlights

On average, it takes about 10-12 years and $1 billion to bring a new drug to market. With a patent life of only 20 years, this does not leave a long market exclusivity period in which to recoup the development costs. Therefore, executives are beginning to look at various technology solutions to lower costs and reduce time-to-market.

Companies are shifting away from the 'one-size-fits-all' blockbuster drug business model. As pressures grow to fill their dwindling product pipeline with innovative drugs, companies are embracing biotechnology and personalized medicine. This has led to a greater demand for the IT sector to provide the industry with the tools it requires to succeed.

In the past, pharma companies have built their own solutions
'/>"/>

SOURCE Reportlinker
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. Reportlinker Adds US Disposable Medical Supplies Market Report
2. Reportlinker Adds Gilead Sciences Inc.: PharmaVitae Profile
3. Reportlinker Adds Drug Delivery Partnering Agreements in Pharma and Biotech
4. Reportlinker Adds Global Medical Devices Industry Outlook to 2010: Marketing And Sales Strategies And The Impact of Recession And Recovery
5. Reportlinker Adds Reinventing Pharmaceutical Sales Forces
6. Reportlinker Adds Computer Assisted Coding Of Medical Information Market Shares, Strategies, and Forecasts 2008 to 2014
7. Reportlinker Adds Global Drug Manufacturing Industry Outlook to 2010: Marketing and Sales Strategies and the Impact of Recession and Recovery
8. Reportlinker Adds Global Anesthesia and Respiratory Devices Market Analysis and Forecasts to 2015
9. Reportlinker Adds The Middle Eastern Pharmaceutical Market Outlook To 2014: Policy environment, market structure, competitive landscape, growth opportunities
10. Reportlinker Adds Global Top 10 Chemical Companies -- Industry, Financial and SWOT Analysis
11. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... Calif. , May 21, 2013   ... announced today the publication of study results involving ... CyberKnife® Robotic Radiosurgery System, the most widely used ... The study followed 304 patients for a median ... post-treatment and found that 97 percent of patients ...
(Date:5/21/2013)... 21, 2013  Healthcare organizations expanding into emerging markets ... , India and ... no shortcuts.  This is proving particularly challenging, considering the ... must change the dialogue around BRIC, as it is ... and building regional partnerships to build a sustainable business. ...
(Date:5/21/2013)... 2013  BioRestorative Therapies, Inc. ("BRT" or the "Company") ... developing stem cell based therapies for various personal applications, ... President and CEO, will be presenting at the Marcum ... held on Thursday, May 30, 2013 at the Grand ... New York City.  Mr. Weinreb,s presentation will take place ...
Breaking Medicine Technology:New Data Validates CyberKnife SBRT for Prostate Cancer Treatment 2New Data Validates CyberKnife SBRT for Prostate Cancer Treatment 3Frost & Sullivan: BRIC is Not Delivering Promises of High Growth in Healthcare Markets 2Frost & Sullivan: BRIC is Not Delivering Promises of High Growth in Healthcare Markets 3Frost & Sullivan: BRIC is Not Delivering Promises of High Growth in Healthcare Markets 4BioRestorative Therapies, Inc. to Present at the Marcum MicroCap Conference 2BioRestorative Therapies, Inc. to Present at the Marcum MicroCap Conference 3
... track to report primary study results in third quarter ... (Nasdaq: NVAX ) announced today that enrollment ... trial of its trivalent virus-like particle (VLP) seasonal influenza ... evaluating a VLP vaccine against the H3N2, H1N1, and ...
... - Data on BIBW 2992, an Irreversible, Dual EGFR ... Treatment of NSCLC Patients with EGFR Activating Mutations - ... Ovarian Cancer-RIDGEFIELD, Conn., May 14 Boehringer Ingelheim will ... compounds, BIBW 2992 and BIBF 1120 at the 2009 ...
Cached Medicine Technology:Novavax Completes Enrollment of Its Second Phase II Seasonal Influenza VLP Vaccine Clinical Trial 2Novavax Completes Enrollment of Its Second Phase II Seasonal Influenza VLP Vaccine Clinical Trial 3Boehringer Ingelheim to Present New Phase II Clinical Data on Two Lead Oncology Compounds at ASCO 2009 2Boehringer Ingelheim to Present New Phase II Clinical Data on Two Lead Oncology Compounds at ASCO 2009 3Boehringer Ingelheim to Present New Phase II Clinical Data on Two Lead Oncology Compounds at ASCO 2009 4Boehringer Ingelheim to Present New Phase II Clinical Data on Two Lead Oncology Compounds at ASCO 2009 5Boehringer Ingelheim to Present New Phase II Clinical Data on Two Lead Oncology Compounds at ASCO 2009 6Boehringer Ingelheim to Present New Phase II Clinical Data on Two Lead Oncology Compounds at ASCO 2009 7Boehringer Ingelheim to Present New Phase II Clinical Data on Two Lead Oncology Compounds at ASCO 2009 8Boehringer Ingelheim to Present New Phase II Clinical Data on Two Lead Oncology Compounds at ASCO 2009 9Boehringer Ingelheim to Present New Phase II Clinical Data on Two Lead Oncology Compounds at ASCO 2009 10
(Date:5/21/2013)... GA (PRWEB) May 21, 2013 Patients of ... Care who have lost teeth due to gum disease and ... surgery for gum disease treatment with laser gum surgery. ... which have the highest success rate out of all tooth ... (LANAP) is a relatively new procedure cleared by the Food ...
(Date:5/21/2013)... Kan. Primary care practice transformation on a ... care reform efforts aimed at achieving better outcomes, ... emerging evidence that transformation toward the patient-centered medical ... health care environment, the U.S. Department of Health ... Quality funded 14 studies to learn more about ...
(Date:5/21/2013)... May 21, 2013 Parker Waichman LLP, ... of victims injured by defective medical devices, is addressing ... Joint Surgery on May 15, 2013. The study found ... identify complications that occur in patients with metal-on-metal hip ... ( http://www.jbjs.org/article.aspx?articleid=1684770 ) , “We’ve known ...
(Date:5/21/2013)... 21, 2013 Artisan Business Group ... Summit: Dealmakers Conference in Long Beach, California on ... on exploring alternative finance through EB-5 immigrant investors ... legal and economic information, and updates to project ... within the EB-5 industry. , "Our goal ...
(Date:5/21/2013)... 2013 Arizona State University is ... to develop their ideas into solutions, products and ... The university is recruiting participants for AREA48 (Applied ... that provides early-stage entrepreneurs with opportunities to access ... to anyone, ASU is particularly seeking participation from ...
Breaking Medicine News(10 mins):Health News:Shenk Dental Care Stimulates Bone Growth for Gum Disease Patients Seeking Dental Implants with Laser Gum Surgery in Atlanta, GA 2Health News:AHRQ-funded journal supplement offers lessons on primary care practice transformation 2Health News:AHRQ-funded journal supplement offers lessons on primary care practice transformation 3Health News:AHRQ-funded journal supplement offers lessons on primary care practice transformation 4Health News:AHRQ-funded journal supplement offers lessons on primary care practice transformation 5Health News:AHRQ-funded journal supplement offers lessons on primary care practice transformation 6Health News:Parker Waichman LLP Comments on New Study Showing that MRI is Useful for Predicting Failure of Metal-on-Metal Hip Implants 2Health News:Parker Waichman LLP Comments on New Study Showing that MRI is Useful for Predicting Failure of Metal-on-Metal Hip Implants 3Health News:Artisan Business Group to Host EB-5 Investment Conference in Long Beach, California 2Health News:ASU Launches Summer Program for Aspiring Entrepreneurs, Innovators and Inventors 2Health News:ASU Launches Summer Program for Aspiring Entrepreneurs, Innovators and Inventors 3Health News:ASU Launches Summer Program for Aspiring Entrepreneurs, Innovators and Inventors 4
... the ban on mercury based flu vaccines given to pregnant ... six weeks . This decision was made due to a ... free children's vaccine is manufactured by Sanofi pasteur, and the ... speed up production to meet the state's need. ,The ...
... new artificial pump along with the intake of certain drugs ... say scientists in Britain.// ,The temporary pumps, known ... patients with severe heart failure while they await transplantation, reported ... on the work of one of the heart's four chambers, ...
... biggest killer disease in the UK during the 1800s has made ... to 2005. //Th number of cases have been rising from the ... , causing great concern to government health agencies. ,The ... Louis Stevenson , was thought to have been conquered by very ...
... unhappy lot because nearly 50 percent of the clan is ... in their careers.// A new study has claimed that nearly ... of chemicals, soaps and shampoos that render constantly moist hands., ... careers, unable to carry on with their jobs when the ...
... abused in early stages of life may grow up to ... University of Chicago. //This study was conducted on baby rhesus ... may lead to the production of less seratonin, a chemical ... causes anxiety and depression.It may also lead to impulsive aggression ...
... down with acute symptoms of dengue, later confirmed positive for ... alarming figure of 741. ,Nearly 31 deaths have ... Peshawar. The National Institute of Health (NIH) has reiterated via ... the disease are pouring in from all over Pakistan which ...
Cached Medicine News:Health News:New Device May Help Heal A Failing Heart 2Health News:TB Returns , Sharp Rise In Cases In UK 2Health News:Hair-raising issues of hairdressers 2Health News:An abused child may grow up to be an abusive parent 2Health News:An abused child may grow up to be an abusive parent 3
Valleylab Surgistat II generator provides exceptional performance, reliability, and safety benefits in a compact, easy to use unit....
Sabre 180, 230V, 50Hz is a powerful niche generator....
Microcontroller-based isolated electrosurgical generator, designed for all general purpose surgical procedures. Unit includes: Instant Response technology, adaptive REM system, isolated output, CEM c...
Maddox rod and occluder...
Medicine Products: